IFNA1 and Patent ductus arteriosus: And most relevantly, elevated tumor IFN signaling gene expression was correlated with poorer prognosis in patients with PDA, which might serve as a marker to predict the patients’ poorer response to therapeutic T cell treatments and lower overall survival rate.